Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families

Human Mutation

Volumn 31, Issue 8, 2010, Pages 950-960

  Igreja, Susana ^a   Chahal, Harvinder S ^a   King, Peter ^a   Bolger, Graeme B ^b   Srirangalingam, Umasuthan ^a   Guasti, Leonardo ^a   Chapple, J Paul ^a   Trivellin, Giampaolo ^a   Gueorguiev, Maria ^a   Guegan, Katie ^c   Stals, Karen ^c   Khoo, Bernard ^d   Kumar, Ajith V ^e   Ellard, Sian ^c   Grossman, Ashley B ^a   Korbonits, Márta ^a   Akker, Scott ^f   Atkinson, Brew ^f   Aylwin, Simon ^f   Baldeweg, Stephanie ^f   Bevan, John ^f   Cheetham, Tim ^f   Chew, Shern ^f   Choudry, Kiran ^f   Clayton, Richard ^f   Damjanovic, Svetozar ^f   Darzy, Ken ^f   Dattani, Mehul ^f   Davis, Julian ^f   Drake, Will ^f   Dzeranova, Larisa ^f   Edén, Britt ^f   Eguchi, Kuniki ^f   Fica, Simona ^f   Flanagan, Daniel ^f   Frohman, Lawrence ^f   Gadelha, Monica ^f   Gallego, Patricia ^f   Gláz, Edit ^f   Goldman, James ^f   Goldstone, Tony ^f   Howlett, Trevor ^f   Inder, Warrick ^f   Iwata, Takeo ^f   Kaplan, Felicity ^f   Karavitaki, Niki ^f   Laws, Ed ^f   Lechan, Ron ^f   Levy, Miles ^f   Matsuno, Akira ^f   Miljic, Dragana ^f   Modenesi, Silvia ^f   Molitch, Mark ^f   Musat, Mâdâlina ^f   Orme, Steve ^f   Patócs, Attila ^f   Popovic, Vera ^f   Powell, Michael ^f   Quinton, Richard ^f   Randeva, Harpal ^f   Ribeiro De Oliveira Jr , Antônio ^f   Schöfl, Christof ^f   Soares, Beatriz ^f   Spada, Anna ^f   Strasburger, Christian ^f   Swords, Francesca ^f   Tsagarakis, Stylianos ^f   Vaks, Vladimir ^f   Wass, John A H ^f   Widell, Hakan ^f   Yarman, Sema ^f   Yoshimoto, Katsuhiko ^f   more..

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f NONE

Author keywords

Acromegaly; AIP; FIPA; Pituitary adenoma; Tumor suppressor

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN; BETA GALACTOSIDASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; LUCIFERASE; MESSENGER RNA; UNCLASSIFIED DRUG; ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN; CYCLIC AMP; MUTANT PROTEIN; RNA SPLICING; SIGNAL PEPTIDE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; COMPUTER MODEL; CONTROLLED STUDY; DNA SPLICING; EXON; FAMILIAL ISOLATED PITUITARY ADENOMA; FEMALE; GENE CONSTRUCT; GENE DELETION; GENE MUTATION; GENETIC COUNSELING; HUMAN; HYPOPHYSIS ADENOMA; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA SPLICING; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; ADULT; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; ENZYMOLOGY; FAMILY; GENE EXPRESSION REGULATION; GENETICS; HYPOPHYSIS TUMOR; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; PEDIGREE; RAT;

ADULT; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FAMILY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; MUTATION, MISSENSE; PEDIGREE; PITUITARY NEOPLASMS; PROMOTER REGIONS, GENETIC; RATS; RNA SPLICE SITES; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 77955078517     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21292     Document Type: Article

References (47)

1. Beckers A, Daly AF. 2007. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 157:371-382. (Pubitemid 350018439)
2. INK4c) gene mutations in a large cohort of pediatric patients with pituitary adenomas occurring in isolation or with associated syndromic features. Proc of the 90th Annual Meet of the Endocrine Soc; OR38-1.
3. Bertherat J, Chanson P, Montminy M. 1995. The cyclic adenosine 3′,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol Endocrinol 9:777-783.
4. Bolger GB, Peden AH, Steele MR, MacKenzie C, McEwan DG, Wallace DA, Huston E, Baillie GS, Houslay MD. 2003. Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. J Biol Chem 278:33351-33363.
5. Buchbinder S, Bierhaus A, Zorn M, Nawroth PP, Humpert P, Schilling T. 2008. Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas. Exp Clin Endorcrinol Diabetes 116:625-628.
6. Cazabat L, Libe R, Perlemoine K, Rene-Corail F, Burnichon N, Gimenez-Roqueplo AP, Dupasquier-Fediaevsky L, Bertagna X, Clauser E, Chanson P, Bertherat J, Raffin-Sanson ML. 2007. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Eur J Endocrinol 157:1-8.
7. Chahal HS, Chapple JP, Frohman LA, Grossman AB, Korbonits M. 2010. Clinical, genetic and molecular characterisation of patients with familial isolated pituitary adenomas. Trends Endocrinol Metab (in press).
8. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabate MI, Bertagna X, Garcia BN, Stalldecker G, Colao A, Ferolla P, Wemeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montanana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A. 2007. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92:1891-1896. (Pubitemid 46997206)
9. D'Andrea LD, Regan L. 2003. TPR proteins: the versatile helix. Trends Biochem Sci 28:655-662.
10. Das AK, Cohen PW, Barford D. 1998. The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions. EMBO J 17:1192-1199. (Pubitemid 28105498)
11. de Oliveira SK, Hoffmeister M, Gambaryan S, Muller-Esterl W, Guimaraes JA, Smolenski AP. 2007. Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. J Biol Chem 282:13656-13663. (Pubitemid 47100556)
12. Dworakowska D, Wlodek E, Leontiou C, Igreja S, Cakir M, Teng M, Prodromou N, Goth M, Grozinsky-Glasberg S, Gueorguiev M, Kola B, Korbonits M, Grossman A. 2009. Activation of Raf/MEK/ERK and PI3K/Akt/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocr Relat Cancer 16:1329-1338.
13. Farrell WE, Clayton RN. 2000. Molecular pathogenesis of pituitary tumors. Front Neuroendocrinol 21:174-198.
14. Gadelha MR, Prezant TR, Une KN, Glick RP, Moskal SF, Vaisman M, Melmed S, Kineman RD, Frohman LA. 1999. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene. J Clin Endocrinol Metab 84:249-256.
15. Gadelha MR, Une KN, Rohde K, Vaisman M, Kineman RD, Frohman LA. 2000. Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12. J Clin Endocrinol Metab 85:707-714. (Pubitemid 32273658)
16. Georgitsi M, De ME, Cannavo S, Makinen MJ, Tuppurainen K, Pauletto P, Curto L, Weil RJ, Paschke R, Zielinski G, Wasik A, Lubinski J, Vahteristo P, Karhu A, Aaltonen LA. 2008a. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clin Endocrinol (Oxf) 69:621-627.
17. Georgitsi M, Heliovaara E, Paschke R, Kumar AV, Tischkowitz M, Vierimaa O, Salmela P, Sane T, De ME, Cannavo S, Gundogdu S, Lucassen A, Izatt L, Aylwin S, Bano G, Hodgson S, Koch CA, Karhu A, Aaltonen LA. 2008b. Large genomic deletions of aryl hydrocarbon receptor interacting protein (AIP) gene in pituitary adenoma predisposition. J Clin Endocrinol Metab 93:4146-4151.
18. Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Makinen MJ, Vierimaa O, Paschke R, Saeger W, van der Luijt RB, Sane T, Robledo M, De ME, Weil RJ, Wasik A, Zielinski G, Lucewicz O, Lubinski J, Launonen V, Vahteristo P, Aaltonen LA. 2007. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proc Natl Acad Sci USA 104:4101-4105.
19. Guarente L. 1983. Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast. Methods Enzymol 101:181-191. (Pubitemid 13071045)
20. Hidalgo-de-Quintana J, Evans RJ, Cheetham ME, van der Spuy J. 2008. The Leber congenital amaurosis protein AIPL1 functions as part of a chaperone heterocomplex. Invest Ophthalmol Vis Sci 49:2878-2887.
21. Horvath A, Stratakis CA. 2008. Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors. Rev Endocr Metab Disord 9:1-11.
22. Igreja SC, Chahal HS, Leontiou CA, Bolger GB, Chapple JP, Grossman AB, Korbonits M. 2010. Functional characterisation of aryl hydrocarbon receptor interacting protein (AIP) promoter and silent mutations. Endocr Abstr 21:P210.
23. Iwata T, Yamada S, Mizusawa N, Golam HM, Sano T, Yoshimoto K. 2007. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas. Clin Endocrinol (Oxf) 66:499-502. (Pubitemid 46434927)
24. Jaffrain-Rea ML, Angelini M, Gargano D, Tichomirowa MA, Daly AF, Vanbellinghen JF, D'Innocenzo E, Barlier A, Giangaspero F, Esposito V, Ventura L, Arcella A, Theodoropoulou M, Naves LA, Fajardo C, Zacharieva S, Rohmer V, Brue T, Gulino A, Cantore G, Alesse E, Beckers A. 2009. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocr Relat Cancer 16:1029-1043.
25. Jennings J, Georgitsi M, Holdaway I, Daly A, Tichomirowa M, Beckers A, Aaltonen L, Karhu A, Cameron F. 2009. Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene. Eur J Endocrinol 161:799-804.
26. Kelley LA, Sternberg MJ. 2009. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4:363-371.
27. Laenger A, Lang-Rollin I, Kozany C, Zschocke J, Zimmermann N, Ruegg J, Holsboer F, Hausch F, Rein T. 2009. XAP2 inhibits glucocorticoid receptor activity in mammalian cells. FEBS Lett 583:1493-1498.
28. Leontiou CA, Gueorguiev M, van der SJ, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Wass JA, Popovic V, Ribeiro-Oliveira Jr A, Gadelha MR, Monson JP, Akker SA, Davis JR, Clayton RN, Yoshimoto K, Iwata T, Matsuno A, Eguchi K, Musat M, Flanagan D, Peters G, Bolger GB, Chapple JP, Frohman LA, Grossman AB, Korbonits M. 2008. The role of the AIP gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 93:2390-2401.
29. Lin BC, Sullivan R, Lee Y, Moran S, Glover E, Bradfield CA. 2007. Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality. J Biol Chem 282:35924-35932.
30. Matsuno A, Teramoto A, Yamada S, Kitanaka S, Tanaka T, Sanno N, Osamura RY, Kirino T. 1994. Gigantism in sibling unrelated to multiple endocrine neoplasia: case report. Neurosurgery 35:952-955.
31. McCarthy MI, Noonan K, Wass JA, Monson JP. 1990. Familial acromegaly: studies in three families. Clin Endocrinol (Oxf) 32:719-728.
32. Melmed S. 2006. Medical progress: acromegaly. N Eng J Med 355:2558-2573.
33. Montanana CF, Daly AF, Tichomirowa MA, Vanbellinghen JF, Jaffrain-Rea ML, Trescoli Serrano C, Riesgo Suares P, Gomez Vela J, Tenes S, Bours V, Beckers A. 2009. TSH-secreting pituitary adenoma in a male patient with a novel missense AIP mutation. Proc of the 91st Annual Meet of the Endocrine Soc; P1-668.
34. Oesch-Bartlomowicz B, Huelster A, Wiss O, ntoniou-Lipfert P, Dietrich C, Arand M, Weiss C, Bockamp E, Oesch F. 2005. Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways. Proc Natl Acad Sci USA 102:9218-9223.
35. Ogino S, Wilson RB, Gold B, Flodman P. 2007. Bayesian risk assessment in genetic testing for autosomal dominant disorders with age-dependent penetrance. J Genet Couns 16:29-39.
36. Pestell RG, Alford FP, Best JD. 1989. Familial acromegaly. Acta Endocrinol (Copenh) 121:286-289.
37. Petrulis JR, Perdew GH. 2002. The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem Biol Interact 141:25-40.
38. Raitila A, Georgitsi M, Karhu A, Tuppurainen K, Makinen MJ, Birkenkamp-Demtroder K, Salmenkivi K, Orntoft TF, Arola J, Launonen V, Vahteristo P, Aaltonen LA. 2007. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia. Endocr Relat Cancer 14:901-906.
39. Rohlff C, Ahmad S, Borellini F, Lei J, Glazer RI. 1997. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J Biol Chem 272:21137-21141. (Pubitemid 27373973)
40. Sikorski RS, Boguski MS, Goebl M, Hieter P. 1990. A repeating amino acid motif in CDC23 defines a family of proteins and a new relationship among genes required for mitosis and RNA synthesis. Cell 60:307-317.
41. Soares BS, Eguchi K, Frohman LA. 2005. Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas. J Clin Endocrinol Metab 90:6580-6587. (Pubitemid 41759319)
42. Tahir A, Chahal HS, Korbonits M. 2010. Molecular genetics of the AIP gene in familial pituitary tumorigenesis. Prog Brain Res (in press).
43. Toledo RA, Lourenco Jr DM, Liberman B, Cunha-Neto MB, Cavalcanti MG, Moyses CB, Toledo SP, Dahia PL. 2007. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. J Clin Endocrinol Metab 92:1934-1937.
44. Vargiolu M, Fusco D, Kurelac I, Dirnberger D, Baumeister R, Morra I, Melcarne A, Rimondini R, Romeo G, Bonora E. 2009. The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability. J Clin Endocrinol Metab 94:2571-2578.
45. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De ME, Makinen MJ, Launonen V, Karhu A, Aaltonen LA. 2006. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228-1230.
46. Yamada S, Yoshimoto K, Sano T, Takada K, Itakura M, Usui M, Teramoto A. 1997. Inactivation of the tumor suppressor gene on 11q13 in brothers with familial acrogigantism without multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 82:239-242. (Pubitemid 27021304)
47. Yaneva M, Daly AF, Tichomirowa MA, Vanbellinghen JF, Hagelstein MT, Bours V, Zacharieva S, Beckers A. 2008. Aryl hydrocarbon receptor interacting protein gene mutations in bulgarian FIPA and young sporadic pituitary adenoma patients. Proc of the 90th Annual Meet of the Endocrine Soc:P3-520.